William Blair & Company
OFIX icon

William Blair & Company’s Orthofix Medical OFIX Stock Holding History

William Blair & Company’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-28,001
Closed -$1.3M – 1465
2017
Q2 		$1.3M Buy
+28,001
New +$1.16M 0.01% 678

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return

William Blair & Company's OFIX Position: Q3 2017 in Review

William Blair & Company sold out of Orthofix Medical (OFIX) in Q3 2017, closing a stake of 28,001 shares — an estimated $1.3M sold.

William Blair & Company first reported a position in OFIX in Q2 2017 and held it in 1 quarter. The position peaked at $1.3M in Q2 2017. 147 funds tracked by Wall St. Rank hold OFIX as of Q3 2017.

  • William Blair & Company reported no remaining Orthofix Medical position as of Q3 2017 after selling out during the quarter.
  • William Blair & Company sold 28,001 Orthofix Medical shares in Q3 2017, an estimated $1.3M.
  • William Blair & Company first reported a position in Orthofix Medical in Q2 2017 and held it in 1 quarter.
  • William Blair & Company's Orthofix Medical position peaked at $1.3M in Q2 2017.
  • 147 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2017.

Based on William Blair & Company's 13F filing for Q3 2017, filed 13 Nov 2017.